ACTRN12612000043831Recruiting未知
A pilot study to determine the performance characteristics of a novel urine based bladder cancer test (uRNA-2) which detects RNA markers in urine, on patients undergoing monitoring for recurrence of bladder cancer
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Pacific Edge Ltd
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 65 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •1.Positive diagnosis for urinary tract TCC over the past 5 years by;
- •cystoscopy and confirmation by histopathological examination of resected tissue
- •confirmation by histopathological examination of biopsy tissue
- •2.Patient is undergoing investigative cystoscopies for the monitoring of recurrence of urinary tract TCC at intervals prescribed by clinical practitioner
- •3.Able to provide a voided urine sample of the required minimum volume
- •4.Able to give written informed consent
- •5.Able and willing to comply with study requirements
Exclusion Criteria
- •1.Prior genitourinary manipulation in the 14 days before urine collection,
- •2.Current symptoms specific to urinary tract infection as evident on preliminary examination
- •3.Current or known history of urinary tract inflammatory disorder,
- •4.Recent history of glomerulonephritis, nephrosis or other renal inflammatory disorders,
- •5.Recent history of pyelonephritis
- •6.Total cystectomy of the bladder
Investigators
Similar Trials
Recruiting
Not Applicable
An observational study of the uRNA-2 urine test for the monitoring of recurrence of urinary tract transitional cell carcinoma (TCC)Bladder CancerCancer - BladderACTRN12612000042842Pacific Edge PTY Ltd.300
Not yet recruiting
Not Applicable
A clinical study for safety and efficacy of a device automatically remove saliva and other fluid and other secretions from the airway ans also does mouthwash for the intubated patients.CTRI/2018/04/013291Coeo Labs private Limited
Completed
Not Applicable
A Pilot Study of the Feasibility and Accuracy of the TrueVie CGM System - A Non-Significant Risk StudyContinuous Glucose MonitoringNCT05348928Sinocare Meditech Inc.16
Completed
Not Applicable
Pilot study to test and validate the applicability of a bioanalytical assay for betahistine in plasma after administration of a single dose betahistine 24 mg IR tabletCTRI/2011/08/001934Abbott Healthcare Products BV8
Completed
Not Applicable
Pilot study for the evaluation, development and implementation of a breath test to diagnose oral candidiasisB37.0Candidal stomatitisDRKS00009391Charité Campus Charité Mitte20